Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

GSK gets maintenance indication for Trelegy

GSK gets maintenance indication for Trelegy

GSK is hoping for a pull-through effect for its two-drug combinations, which are facing increasing competition from other duos for COPD from rivals Novartis, AstraZeneca and Boehringer Ingelheim.

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more There’s lots more Q1 results today:in addition to Roche, we have AbbVie, AstraZeneca, BMS, Celgene, and Vertex.

AZ’s immuno-oncology combo fails another lung cancer trial

AZ’s immuno-oncology combo fails another lung cancer trial Shares in AstraZeneca were on the slide this morning after its combination of Imfinzi and tremelimumab failed to hit the mark in a phase III lung cancer trial.

Merck preps regulatory filings for much-needed antibiotic combo

Merck preps regulatory filings for much-needed antibiotic combo missed its primary endpoint, as well as Entasis/AstraZeneca’s zoliflodacin and GlaxoSmithKline’s gepotidacin, which are in phase II.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics